Document Detail

Design of new anti-viral agents for chronic hepatitis B virus infection.
MedLine Citation:
PMID:  1751799     Owner:  NLM     Status:  MEDLINE    
The effectiveness of therapies for chronic hepatitis B will depend on their ability to inhibit all HBV replicative intermediates including viral SC DNA as well as stimulating the host's immune system to clear virus and produce sustained immunity. Future therapies will require the use of combined treatments in 'cocktail-type arrangements' as outlined in this paper, linked with careful staging of the hepatitis B carrier state.
S Locarnini
Related Documents :
20871629 - Il-15 increases the frequency of effector memory cd8+ t cells in rhesus monkeys immuniz...
23217809 - Self-reported adherence supports patient preference for the single tablet regimen (str)...
18845919 - Vasculitides in the context of hiv infection.
20412879 - Mucosal hiv vaccines: a holy grail or a dud?
12772669 - Immune-based therapies in brief.
15030769 - Immunobiology of mucosal hiv infection and the basis for development of a new generatio...
15514099 - Liver dysfunction and steatosis in familial hypobetalipoproteinemia.
25284989 - Acceptability of bone antiresorptive therapy among hiv-infected adults at different sta...
14968219 - Prevalence of hepatitis c virus among bilharziasis patients.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  6 Suppl 1     ISSN:  0815-9319     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:  1991  
Date Detail:
Created Date:  1992-01-27     Completed Date:  1992-01-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  18-22     Citation Subset:  IM    
Hepatitis Research Unit, Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents* / therapeutic use
Drug Design*
Hepatitis B / drug therapy*
Hepatitis B virus / drug effects,  physiology
Hepatitis, Chronic / drug therapy*
Virus Replication / drug effects
Reg. No./Substance:
0/Antiviral Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients.
Next Document:  Dedifferentiation phenomena after denervation of mammalian adult vestibular receptors.